Bio-Rad Laboratories (BIO) Return on Invested Capital Growth (3y) (2013 - 2026)
Bio-Rad Laboratories (BIO) Return on Invested Capital Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | 0.00 |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 0.00 |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 1.00 |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 0.00 |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | -85.00 |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 0.00 |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | 2.00 |
| 10 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | -154.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -154.00 |
| Mar 31, 2026 | -160.00 |
| Dec 31, 2025 | -189.00 |
| Sep 30, 2025 | -109.00 |
| Jun 30, 2025 | -71.00 |
| Mar 31, 2025 | 7.00 |
| Dec 31, 2024 | 37.00 |
| Sep 30, 2024 | 99.00 |
| Jun 30, 2024 | 131.00 |
| Mar 31, 2024 | 119.00 |
| Dec 31, 2023 | 129.00 |
| Sep 30, 2023 | 160.00 |
| Jun 30, 2023 | 154.00 |
| Mar 31, 2023 | 160.00 |
| Dec 31, 2022 | 196.00 |
| Sep 30, 2022 | 145.00 |
| Jun 30, 2022 | 106.00 |
| Mar 31, 2022 | 45.00 |
| Dec 31, 2021 | 31.00 |
| Sep 30, 2021 | 2.00 |